According to a Reuters news, AstraZeneca Plc (AZN.L) cited a study on Tuesday to say that its vaccine is effective against delta and kappa variants, which were first identified in India.
(adsbygoogle = window.adsbygoogle || []).push({});
London. There is increasing concern around the world regarding new variants of the corona virus. Four states in India have been put on alert after getting 40 cases of Delta Plus variant. Meanwhile, Britain’s AstraZeneca Vaccine has claimed that its vaccine is effective on Delta, a new form of corona found in India. Prior to this, only America’s vaccine Pfizer has been considered effective against Delta variants.
According to a Reuters news, AstraZeneca Plc (AZN.L) cited a study on Tuesday to say that its vaccine is effective against delta and kappa variants, which were first identified in India.
company said in the statement, the Oxford University investigated the ability of monoclonal antibodies in the blood of vaccinated people, the ability to neutralize delta and kappa variants. is. Its results have been very good.
An analysis by Public Health England (PHE) last week showed that vaccines made by Pfizer Inc. (PFE.N) and AstraZeneca give more than 90% protection against those infected with the delta variant. The company said that the new Oxford study is also based on the analysis of PHE.
The Chief Scientist of the World Health Organization said on Friday that the delta variant could spread globally. WHO has said that the corona virus vaccine is found to be less effective on this variant. However, there is a relief that the vaccine reduces the risk of death and prevents serious disease.
